Updated Jul 16, 2026
Pontifax Management 4 G.P. (2015) Ltd. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $15.00M. Lifetime open-market sales: $84.98M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-10-15 | KROS | Keros Therapeutics, Inc. | S — Open-market sale | 155.3K | $17.75 | $2.76M |
| 2025-10-15 | KROS | Keros Therapeutics, Inc. | S — Open-market sale | 1.23M | $17.75 | $21.77M |
| 2025-10-15 | KROS | Keros Therapeutics, Inc. | S — Open-market sale | 1.12M | $17.75 | $19.90M |
| 2025-10-15 | KROS | Keros Therapeutics, Inc. | S — Open-market sale | 2.28M | $17.75 | $40.55M |
| 2025-09-12 | LBRX | LB PHARMACEUTICALS INC | P — Open-market purchase | 1.00M | $15.00 | $15.00M |
| 2025-09-12 | LBRX | LB PHARMACEUTICALS INC | J — Other acquisition / disposition | 411.7K | — |
Pontifax Management 4 G.P. (2015) Ltd. is a corporate insider — currently tracked as 10% Owner. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 1 open-market purchases ($15.00M) and 4 open-market sales ($84.98M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Pontifax Management 4 G.P. (2015) Ltd. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.